Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPMPC Peripheral CMV Retinitis Trial (HPCRT)
NCT00000142Phase 3Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Apr 1994
- Primary completion
- Feb 1996
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cidofovir in cytomegalovirus retinitis (3 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoint: Overall Survival. Started Apr 1994; status: completed.
02
Drugs
cidofovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000142.